当前蛋白身份:P04004 重新检索
本组结构的主要差异维度
构建体不同 突变/修饰不同 组装状态不同 配体/离子不同 实验方法不同 实验环境不同 结构质量指标不同

差异标签只比较当前检索结果;所有PDB和assembly原始记录仍分别保留。

相关结构差异明细

一行代表一个 PDB 条目中的一个 biological assembly;同一蛋白的多个单体会分别列出。

PDB 条目 Assembly / 聚集状态 构建体 突变与修饰 配体、离子与非聚合物 实验方法 实验环境 结构质量
1OC0 plasminogen activator inhibitor-1 complex with somatomedin B domain of vitronectin 提交 2003-02-03 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 20–70(51 aa) 片段:SOMATOMEDIN B, RESIDUES 20-70
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 pH 7.4;10MM NAOAC, 50MM NACL, 2-9% PEG12000,25% PEG400, 50MM HEPES, PH 7.4
分辨率 2.28 Å R-free 0.252
1S4G Somatomedin-B Domain of human plasma vitronectin. 提交 2004-01-16 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–70(51 aa) 片段:Somatomedin B
未记录 未记录非水小分子 SOLUTION NMR
NMR测量条件 pH 4.4;298 K;离子强度(mmCIF原始值)low
NMR样品组成 Isolated from human plasma vitronectin by CNBr cleavage
分辨率未提供
1SSU Structural and biochemical evidence for disulfide bond heterogeneity in active forms of the somatomedin B domain of human vitronectin 提交 2004-03-24 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–70(51 aa) 片段:somatomedin B domain of human vitronectin
未记录 未记录非水小分子 SOLUTION NMR
NMR测量条件 pH 7.5;293 K;离子强度(mmCIF原始值)180 mM;压力 1
NMR测量条件 pH 7.5;293 K;离子强度(mmCIF原始值)180 mM;压力 1
NMR样品组成 N15-labeled protein 20 mM sodium phosphate pH 7.5 | 90% H2O/10% D2O
NMR样品组成 unlabeled protein 20 mM sodium phosphate pH 7.5 | 90% H2O/10% D2O
分辨率未提供
2JQ8 Solution structure of the Somatomedin B domain from vitronectin produced in Pichia pastoris 提交 2007-05-30 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–66(47 aa) 片段:sequence database residues 20-66
未记录 未记录非水小分子 SOLUTION NMR
NMR测量条件 pH 6.5;298 K;离子强度(mmCIF原始值)0;压力 ambient
NMR样品组成 0.4 mM [U-99% 13C; U-99% 15N] SMB, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR样品组成 0.7 mM SMB, 90% H2O/10% D2O | 90% H2O/10% D2O
分辨率未提供
3BT1 Structure of urokinase receptor, urokinase and vitronectin complex 提交 2007-12-27 Assembly 1 其他组合 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 B 21–60(40 aa) 片段:sometomedin-B domain
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 X-RAY DIFFRACTION
X-ray结晶条件 MICRODIALYSIS;pH 7.5;295 K;12% PEG 3350, 50mM HEPES pH 7.5, MICRODIALYSIS, temperature 295K
分辨率 2.80 Å R-free 0.308
3BT2 Structure of urokinase receptor, urokinase and vitronectin complex 提交 2007-12-27 Assembly 1 其他组合 异源复合物;蛋白 × 5 PDB 声明:pentameric(5) 与蛋白数一致
链 B 21–60(40 aa) 片段:sometomedin-B domain
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray结晶条件 MICRODIALYSIS;pH 7.5;295 K;8% PEG 4000, 2.5% ethanol, 0.05% sodium azide, 50mM cacodylate pH 6.5, pH 7.5, MICRODIALYSIS, temperature 295K
分辨率 2.50 Å R-free 0.272
3BT2 Structure of urokinase receptor, urokinase and vitronectin complex 提交 2007-12-27 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 21–60(40 aa) 片段:sometomedin-B domain
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 MICRODIALYSIS;pH 7.5;295 K;8% PEG 4000, 2.5% ethanol, 0.05% sodium azide, 50mM cacodylate pH 6.5, pH 7.5, MICRODIALYSIS, temperature 295K
分辨率 2.50 Å R-free 0.272
4K24 Structure of anti-uPAR Fab ATN-658 in complex with uPAR 提交 2013-04-08 Assembly 1 其他组合 异源复合物;蛋白 × 5 PDB 声明:pentameric(5) 与蛋白数一致
链 B 21–60(40 aa) 片段:UNP residues 21-60
未记录 MAN alpha-D-mannopyranose × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;295 K;0.1M HEPES pH 7.5, 55%(v/v) Tacsimate, 2%(v/v) 2-methyl-1,3-propanediol, vapor diffusion, sitting drop, temperature 295K
分辨率 4.50 Å R-free 0.275
6O5E Crystal structure of the Vitronectin hemopexin-like domain 提交 2019-03-01 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 154–285(132 aa) 片段:hemopexin-like domain (UNP residues 154-285, 324-354, 435-474)
链 A 324–354(31 aa) 片段:hemopexin-like domain (UNP residues 154-285, 324-354, 435-474)
链 A 435–474(40 aa) 片段:hemopexin-like domain (UNP residues 154-285, 324-354, 435-474)
突变:C180S, C215S 突变:C180S, C215S 突变:C180S, C215S NA SODIUM ION × 2 CL CHLORIDE ION × 1 SO4 SULFATE ION × 1 IMD IMIDAZOLE × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;1 uL protein solution + 1 uL precipitate solution [0.09 M imidazole/MES, pH 6.5, 27 mM sodium nitrate, 27 mM sodium phosphate dibasic, 27 mM ammonium sulfate, 11.25% v/v MPD, 11.25% w/v PEG1000, 11.25% w/v PEG3350, 3% w/v D-(+)-trehalose]
分辨率 1.90 Å R-free 0.210
6O5E Crystal structure of the Vitronectin hemopexin-like domain 提交 2019-03-01 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 154–285(132 aa) 片段:hemopexin-like domain (UNP residues 154-285, 324-354, 435-474)
链 B 324–354(31 aa) 片段:hemopexin-like domain (UNP residues 154-285, 324-354, 435-474)
链 B 435–474(40 aa) 片段:hemopexin-like domain (UNP residues 154-285, 324-354, 435-474)
突变:C180S, C215S 突变:C180S, C215S 突变:C180S, C215S NA SODIUM ION × 2 CL CHLORIDE ION × 1 SO4 SULFATE ION × 2 NO3 NITRATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;1 uL protein solution + 1 uL precipitate solution [0.09 M imidazole/MES, pH 6.5, 27 mM sodium nitrate, 27 mM sodium phosphate dibasic, 27 mM ammonium sulfate, 11.25% v/v MPD, 11.25% w/v PEG1000, 11.25% w/v PEG3350, 3% w/v D-(+)-trehalose]
分辨率 1.90 Å R-free 0.210
7RJ9 Crystal structure of the Vitronectin hemopexin-like domain binding Calcium 提交 2021-07-20 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 154–474(321 aa) 片段:UNP RESIDUES 154-285, 324-354, 435-474
突变:C180S, C215S, delta 286-323, delta 355-434 CA CALCIUM ION × 1 CL CHLORIDE ION × 1 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;1 UL PROTEIN SOLUTION + 1 UL PRECIPITATE SOLUTION contaning 0.09 M IMIDAZOLE/MES, PH 6.5, 27 mM SODIUM NITRATE, 27 mM SODIUM PHOSPHATE, 27 mM AMMONIUM SULFATE, 11.25% V/V MPD, 11.25% W/V PEG1000, 11.25% W/V PEG3350, 3% W/V D- (+)-TREHALOSE. Crystals were soaked with the well solution containing 100 mM CaCl2 and missing SODIUM PHOSPHATE, AMMONIUM SULFATE, and IMIDAZOLE/MES
分辨率 1.70 Å R-free 0.210
7RJ9 Crystal structure of the Vitronectin hemopexin-like domain binding Calcium 提交 2021-07-20 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 154–474(321 aa) 片段:UNP RESIDUES 154-285, 324-354, 435-474
突变:C180S, C215S, delta 286-323, delta 355-434 CA CALCIUM ION × 1 CL CHLORIDE ION × 1 NA SODIUM ION × 1 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;1 UL PROTEIN SOLUTION + 1 UL PRECIPITATE SOLUTION contaning 0.09 M IMIDAZOLE/MES, PH 6.5, 27 mM SODIUM NITRATE, 27 mM SODIUM PHOSPHATE, 27 mM AMMONIUM SULFATE, 11.25% V/V MPD, 11.25% W/V PEG1000, 11.25% W/V PEG3350, 3% W/V D- (+)-TREHALOSE. Crystals were soaked with the well solution containing 100 mM CaCl2 and missing SODIUM PHOSPHATE, AMMONIUM SULFATE, and IMIDAZOLE/MES
分辨率 1.70 Å R-free 0.210